Outlook Therapeutics Inc (OTLK)
7.78
+0.45
(+6.14%)
USD |
NASDAQ |
May 17, 16:00
7.78
0.00 (0.00%)
After-Hours: 20:00
Outlook Therapeutics Cash from Financing (Quarterly): 56.14M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 56.14M |
December 31, 2023 | -0.0032M |
September 30, 2023 | 2.424M |
June 30, 2023 | 3.296M |
March 31, 2023 | -0.5971M |
December 31, 2022 | 43.85M |
September 30, 2022 | 1.626M |
June 30, 2022 | -11.30M |
March 31, 2022 | 2.608M |
December 31, 2021 | 66.66M |
September 30, 2021 | 3.776M |
June 30, 2021 | 2.716M |
March 31, 2021 | 43.35M |
December 31, 2020 | 6.357M |
September 30, 2020 | 0.6608M |
June 30, 2020 | 26.16M |
March 31, 2020 | 10.40M |
December 31, 2019 | -0.0083M |
September 30, 2019 | -0.0688M |
Date | Value |
---|---|
June 30, 2019 | 24.33M |
March 31, 2019 | 6.237M |
December 31, 2018 | 8.528M |
September 30, 2018 | -0.4223M |
June 30, 2018 | 14.56M |
March 31, 2018 | -0.1875M |
December 31, 2017 | 20.40M |
September 30, 2017 | 2.990M |
June 30, 2017 | 5.768M |
March 31, 2017 | 2.156M |
December 31, 2016 | 5.717M |
September 30, 2016 | -0.5048M |
June 30, 2016 | 27.21M |
March 31, 2016 | 4.271M |
December 31, 2015 | 8.888M |
September 30, 2015 | 18.00M |
June 30, 2015 | 18.48M |
March 31, 2015 | 2.853M |
December 31, 2014 | 3.670M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-11.30M
Minimum
Jun 2022
66.66M
Maximum
Dec 2021
14.12M
Average
3.006M
Median
Cash from Financing (Quarterly) Benchmarks
Cutera Inc | -0.26M |
Actinium Pharmaceuticals Inc | 14.77M |
GT Biopharma Inc | 0.00 |
Karyopharm Therapeutics Inc | -- |
Marinus Pharmaceuticals Inc | 0.257M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -19.27M |
Free Cash Flow | -58.26M |
Free Cash Flow Per Share (Quarterly) | -1.350 |
Free Cash Flow Yield | -56.37% |